Scope Fluidics SA (SCP.WA) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Poland · ISIN PLSCPFL00018
Price
148.60 PLN
Market cap
470.81 m PLN
P/E (2025)
–
P/S (2025)
4,708.05
Dividend yield
0.00 %
Net margin
-46,364.00 %
Return on equity (ROE)
-28.54 %
Return on assets (ROA)
-23.66 %
Scope Fluidics SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 131,000.00 PLN | 100,000.00 PLN |
| Gross profit | -1.18 m PLN | -44.40 m PLN |
| Operating income | 77.05 m PLN | -47.23 m PLN |
| EBIT | 85.63 m PLN | -47.23 m PLN |
| Net income | 65.42 m PLN | -46.36 m PLN |
| Diluted EPS – continuing operations | 24.00 PLN | -16.75 PLN |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Scope Fluidics SA
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.
More stocks
- PKP Cargo S.A. (PKP.WA)
- Golden State Bancorp (GSBX)
- Braemar Hotels & Resorts Inc. (BHR)
- Canaan Inc (CAN)
- Kenorland Minerals Ltd (KLD.V)
- Oconee Federal Financial Corp (OFED)
- Rare Earths Americas, Inc. (REA)
- Atomera Inc (ATOM)
- Yunsung F&C Co. Ltd. (372170.KQ)
- DAEYANG ELECTRIC.Co.Ltd (108380.KQ)
- Falco Resources Ltd (FPC.V)
- Cheffelo AB (CHEF.ST)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.